WHIPPANY, N.J. & BOSTON--(BUSINESS WIRE)--ISI, a leading provider of software and services for the life sciences industry, is now offering a suite of integrated regulatory solutions that enables organizations to respond to the varying stages of global acceptance for the electronic Common Technical Document (eCTD). The eCTD – the international standard for life sciences regulatory submissions – promises to make submitting a new drug application to multiple regulators easy and more cost effective, but few firms have been able to reap the benefits. The single, highly configurable solution for assembling, reviewing and compiling/publishing submissions gives companies the ability to easily tailor one submission for multiple markets, many of which are at vastly different stages of eCTD maturity.
